Form 4: Vericel Corp CFO Joseph Mara Sells 9,000 Shares Under 10b5-1 Plan

Vericel Corp's Chief Financial Officer, Joseph Mara, sold 9,000 shares of common stock on March 3, 2025, at a price of $49.53 per share, according to a Form 4 filing with the SEC.

Summary

• Joseph Mara Jr., Chief Financial Officer of Vericel Corp, reported a transaction involving the sale of company stock.
• On March 3, 2025, Mara sold 9,000 shares of Vericel Corp common stock at a price of $49.53 per share.
• The sale was executed under a pre-arranged Rule 10b5-1 trading plan adopted on November 15, 2024.
• Following the transaction, Mara directly owns 13,967 shares of Vericel Corp.
• These shares include shares acquired pursuant to the Issuer's 2015 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c).

Sentiment

Score: 5

Explanation: The document is a standard SEC filing reporting an insider stock sale under a pre-arranged trading plan. It doesn't inherently convey positive or negative sentiment.

Industry Context

This filing is a routine disclosure of insider trading activity. It is common for executives to use 10b5-1 plans to sell shares over time to avoid accusations of trading on inside information.

Stakeholder Impact

• The sale of shares by a company executive could be perceived negatively by some shareholders, although the existence of a 10b5-1 plan mitigates this concern.

Key Dates